Evidence map›Paper›PMID 40512622›Full record

ArticleCell reports2025

De-coupling immune parameters and toxicity associated with IL-12 agonism.

Zachary R Lanzar, Daniel L Aldridge, Bhargavi Jayaraman, Breanne Haskins, Christian A Howard, Kathya Arana, Molly E Bunkofske, Kathleen Mulka, Ryan D Pardy, Jessica Byerly and 3 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Heat-killedFrontiers in immunology · 2026
    Article
  3. IL-27 promotes Treg cell expression of CD122 and fitness at homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zachary R LanzarDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Daniel L AldridgeDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Bhargavi JayaramanSynthekine, 1505 O'Brien Drive, Menlo Park, CA 94025, USA.
Breanne HaskinsDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Christian A HowardDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kathya AranaDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Molly E BunkofskeDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kathleen MulkaDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ryan D PardyDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jessica ByerlyDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Boris StriepenDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Patrick LupardusSynthekine, 1505 O'Brien Drive, Menlo Park, CA 94025, USA.
Christopher A HunterDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: chunter@vet.upenn.edu.

Funding

IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
Transcriptional regulation of vaccine-elicited and infection-elicited CD8+ T cell responsesR01AI066121 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Ross M Kedl · 2007 to 2026
$7.1M
Immunity to CryptosporidiumR01AI148249 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOPHER A HUNTER, BORIS STRIEPEN · 2020 to 2026
$5.3M
Neuronal Latency and ToxoplasmaR01AI157247 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOPHER A HUNTER, Anita Koshy · 2020 to 2026
$4.7M
The role of CD40L in resistance to enteric infectionU01AI163671 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHRISTOPHER A HUNTER, BORIS STRIEPEN · 2021 to 2026
$4.7M
Mechanisms of combined CD40/TLR adjuvant-elicited cellular immunityU01AI160664 · NIAID · UNIVERSITY OF COLORADO DENVER · PI ADAMS, THOMAS A, HUNTER, CHRISTOPHER A · 2021 to 2025
$3.1M
Impact of Toxoplasma gondii on Treg homeostasisF31AI179240 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LANZAR, ZACHARY R · 2024 to 2025
$66k
NCI NIH HHS T32 CA009140NIAID NIH HHS F31 AI179240NIAID NIH HHS R01 AI066121NIAID NIH HHS R01 AI148249NIAID NIH HHS R01 AI157247NIAID NIH HHS U01 AI160664NIAID NIH HHS U01 AI163671
6 · The paper itself

Abstract

Interleukin-12 (IL-12) stimulates natural killer (NK) and T cell production of interferon gamma (IFN-γ), but adverse events from NK cell activation have limited its clinical use. This study shows the impact of half-life-extended, full (IL-12Fc) and partial (IL-12 3x AlaFc) IL-12 agonists on the immune system. In naive mice, serial treatment with IL-12Fc induces systemic IFN-γ, multi-organ pathology, and alterations in myelopoiesis. IL-12 Fc stimulates NK cell production of IFN-γ but also activates CD4

Indexed as

Interleukin-12AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesInterferon-gammaKiller Cells, NaturalLymphocyte ActivationMiceMice, Inbred C57BLMyelopoiesisInterferon-gammaInterleukin-12CP: Immunologyhematopoeisisinfectioninnate and adaptive immunityinterleukin-12toxicity

Identifiers

PMID40512622
PMCPMC12264503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.